Skip to Content

News & Events

Press Release Details

Jun 3, 2015

Vertex to Present at the Goldman Sachs Healthcare Conference on June 11

BOSTON--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that management will participate in a fireside chat at the Goldman Sachs Healthcare Conference in Rancho Palos Verdes, CA on Thursday, June 11th at 12:20 p.m. ET (9:20 a.m. PT).

The audio portion of management's remarks from the conference will be accessible live through Vertex's website at in the "Investors" section under the "Events and Presentations" page. A replay of the conference webcast will be archived on the company's website.

About Vertex

Vertex is a global biotechnology company that aims to discover, develop and commercialize innovative medicines so people with serious diseases can lead better lives. In addition to our clinical development programs focused on cystic fibrosis, Vertex has more than a dozen ongoing research programs aimed at other serious and life-threatening diseases.

Founded in 1989 in Cambridge, Mass., Vertex today has research and development sites and commercial offices in the United States, Europe, Canada and Australia. For five years in a row, Science magazine has named Vertex one of its Top Employers in the life sciences. For additional information and the latest updates from the company, please visit


Vertex Pharmaceuticals Incorporated
Michael Partridge, 617-341-6108
Kelly Lewis, 617-961-7530
Eric Rojas, 617-961-7205

Source: Vertex Pharmaceuticals Incorporated

News Provided by Acquire Media